Aplicación YC de Kernal Biologics

Summer 2020Active

Kernal Biologics pasó por Y Combinator en el batch Summer 2020 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.

Batch YC: Summer 2020
Industria: HealthcareTherapeutics
Tamaño del equipo: 20
Estado: Active
Lanzado: 2020

Fundadores

Yusuf ErkulFounder
Jeff OzdemirFounder
Burak YILMAZFounder

Lo que hace Kernal Biologics

Kernal Bio is a biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted cell delivery and minimal off-target effects. Our KR-402 program achieves over 90% delivery efficiency with T-cell-targeted LNPs, enabling direct CAR-T programming within the body and resulting in B-cell depletion within a week. Kernal Bio is led by a team with experience from MIT, Harvard, Merck, and BMS, boasting three FDA-approved therapies and over 120 patents. Based in Cambridge, MA, we are backed by Hummingbird Ventures, Amgen Ventures, HBM, and even NASA. With roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. Sr. VP of R&D Manfred Kraus is a leader in immuno-oncology, who was most recently Scientific Sr. Director at Bristol-Myers Squibb (BMS).

Aplicación YC de Kernal Biologics, reconstruida

Solicitud de Y Combinator

Kernal Biologics, batch Summer 2020. Las preguntas reales del formulario, respondidas con datos públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Kernal Biologics

Describe what your company does in 50 characters or less.

mRNA 2.0 therapies targeting specific cells

What is your company going to make? Please describe your product and what it does or will do.

We're building selective mRNA-LNP immunotherapies that deliver mRNA precisely to specific immune cells. Our lead program, KR-402, targets T cells to program CAR-T therapies directly in the body and can deplete B cells within a week. This lets us treat cancer and autoimmune diseases with fewer off-target effects than current mRNA approaches.

Where do you live now, and where would the company be based after YC?

We live in Cambridge, MA, and Kernal is based there. After YC, we'd remain in Cambridge because that's where our team, science, and investors are concentrated.

Explain your decision regarding location.

Cambridge is a biotech hub with access to top academic talent and proximity to investors, which is critical for developing complex mRNA therapeutics. Being near MIT and Harvard also helps us recruit and collaborate on cutting-edge science.

21 respuestas más en la aplicación completa

están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.

Ver aplicación completa

Preguntas Frecuentes

¿Es esta la aplicación YC real de Kernal Biologics?

No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Kernal Biologics (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Kernal Biologics se presentaría a YC, no el texto que enviaron.

¿En qué batch de YC estuvo Kernal Biologics?

Kernal Biologics formó parte del batch Summer 2020 de Y Combinator.

¿Quién fundó Kernal Biologics?

Kernal Biologics fue fundado por Yusuf Erkul, Jeff Ozdemir, Burak YILMAZ.

¿A qué se dedica Kernal Biologics?

Kernal is creating mRNA 2.0 therapies that work in specific cells

¿Cómo leo la aplicación completa reconstruida?

Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Kernal Biologics, y de cada otro batch de YC, está en YC Insights.